Patterson Cos. (PDCO - Free Report) reported $1.65 billion in revenue for the quarter ended October 2023, representing a year-over-year increase of 1.6%. EPS of $0.50 for the same period compares to $0.63 a year ago.
The reported revenue compares to the Zacks Consensus Estimate of $1.71 billion, representing a surprise of -3.10%. The company delivered an EPS surprise of -15.25%, with the consensus EPS estimate being $0.59.
While investors closely watch year-over-year changes in headline numbers -- revenue and earnings -- and how they compare to Wall Street expectations to determine their next course of action, some key metrics always provide a better insight into a company's underlying performance.
As these metrics influence top- and bottom-line performance, comparing them to the year-ago numbers and what analysts estimated helps investors project a stock's price performance more accurately.
Here is how Patterson Cos. performed in the just reported quarter in terms of the metrics most widely monitored and projected by Wall Street analysts:
- Net sales- Animal Health: $1.02 billion compared to the $1.06 billion average estimate based on four analysts. The reported number represents a change of +2.2% year over year.
- Net Sales- Animal Health- Consumable: $972.87 million compared to the $1.01 billion average estimate based on four analysts. The reported number represents a change of +0.9% year over year.
- Net Sales- Animal Health- Equipment and software: $30.17 million versus the four-analyst average estimate of $31.84 million. The reported number represents a year-over-year change of +0.9%.
- Net Sales- Animal Health- Value-added services and Other: $21.59 million versus $14.27 million estimated by four analysts on average. Compared to the year-ago quarter, this number represents a +131.1% change.
- Consolidated Net Sales- Consumable- Total: $1.32 billion versus the four-analyst average estimate of $1.36 billion. The reported number represents a year-over-year change of +1.4%.
- Net sales- Corporate: $1.77 million versus the four-analyst average estimate of $4.10 million. The reported number represents a year-over-year change of -131%.
- Consolidated Net Sales- Value-added services and Other- Total: $103.12 million versus $98.58 million estimated by four analysts on average. Compared to the year-ago quarter, this number represents a +27.2% change.
- Net Sales- Dental supply: $626.38 million versus $640.33 million estimated by four analysts on average. Compared to the year-ago quarter, this number represents a -0.4% change.
- Net Sales- Dental supply- Consumable: $346.49 million versus $345.95 million estimated by four analysts on average. Compared to the year-ago quarter, this number represents a +2.7% change.
- Net Sales- Dental supply- Equipment and software: $200.13 million versus the four-analyst average estimate of $214.16 million. The reported number represents a year-over-year change of -6.5%.
- Net sales- Dental supply- Value-added services and other: $79.76 million versus $80.22 million estimated by four analysts on average. Compared to the year-ago quarter, this number represents a +3% change.
- Consolidated Net Sales- Equipment and Software- Total: $230.29 million versus the four-analyst average estimate of $246 million. The reported number represents a year-over-year change of -5.6%.
View all Key Company Metrics for Patterson Cos. here>>>Shares of Patterson Cos. have returned +3.2% over the past month versus the Zacks S&P 500 composite's +10.8% change. The stock currently has a Zacks Rank #3 (Hold), indicating that it could perform in line with the broader market in the near term.
Zacks Names "Single Best Pick to Double"
From thousands of stocks, 5 Zacks experts each have chosen their favorite to skyrocket +100% or more in months to come. From those 5, Director of Research Sheraz Mian hand-picks one to have the most explosive upside of all.
It’s an American AI company that’s riding low right now, but it has rounded up clients like BMW, GE, Dell Computer, and Bosch. It has prospects for not just doubling but quadrupling in the year to come. Of course, all our picks aren’t winners but this one could far surpass earlier Zacks’ Stocks Set to Double like Boston Beer Company which shot up +143.0% in little more than 9 months and NVIDIA which boomed +175.9% in one year.
Free: See Our Top Stock And 4 Runners Up
Patterson Cos. (PDCO - Free Report) reported $1.65 billion in revenue for the quarter ended October 2023, representing a year-over-year increase of 1.6%. EPS of $0.50 for the same period compares to $0.63 a year ago.
The reported revenue compares to the Zacks Consensus Estimate of $1.71 billion, representing a surprise of -3.10%. The company delivered an EPS surprise of -15.25%, with the consensus EPS estimate being $0.59.
While investors closely watch year-over-year changes in headline numbers -- revenue and earnings -- and how they compare to Wall Street expectations to determine their next course of action, some key metrics always provide a better insight into a company's underlying performance.
As these metrics influence top- and bottom-line performance, comparing them to the year-ago numbers and what analysts estimated helps investors project a stock's price performance more accurately.
Here is how Patterson Cos. performed in the just reported quarter in terms of the metrics most widely monitored and projected by Wall Street analysts:
- Net sales- Animal Health: $1.02 billion compared to the $1.06 billion average estimate based on four analysts. The reported number represents a change of +2.2% year over year.
- Net Sales- Animal Health- Consumable: $972.87 million compared to the $1.01 billion average estimate based on four analysts. The reported number represents a change of +0.9% year over year.
- Net Sales- Animal Health- Equipment and software: $30.17 million versus the four-analyst average estimate of $31.84 million. The reported number represents a year-over-year change of +0.9%.
- Net Sales- Animal Health- Value-added services and Other: $21.59 million versus $14.27 million estimated by four analysts on average. Compared to the year-ago quarter, this number represents a +131.1% change.
- Consolidated Net Sales- Consumable- Total: $1.32 billion versus the four-analyst average estimate of $1.36 billion. The reported number represents a year-over-year change of +1.4%.
- Net sales- Corporate: $1.77 million versus the four-analyst average estimate of $4.10 million. The reported number represents a year-over-year change of -131%.
- Consolidated Net Sales- Value-added services and Other- Total: $103.12 million versus $98.58 million estimated by four analysts on average. Compared to the year-ago quarter, this number represents a +27.2% change.
- Net Sales- Dental supply: $626.38 million versus $640.33 million estimated by four analysts on average. Compared to the year-ago quarter, this number represents a -0.4% change.
- Net Sales- Dental supply- Consumable: $346.49 million versus $345.95 million estimated by four analysts on average. Compared to the year-ago quarter, this number represents a +2.7% change.
- Net Sales- Dental supply- Equipment and software: $200.13 million versus the four-analyst average estimate of $214.16 million. The reported number represents a year-over-year change of -6.5%.
- Net sales- Dental supply- Value-added services and other: $79.76 million versus $80.22 million estimated by four analysts on average. Compared to the year-ago quarter, this number represents a +3% change.
- Consolidated Net Sales- Equipment and Software- Total: $230.29 million versus the four-analyst average estimate of $246 million. The reported number represents a year-over-year change of -5.6%.
View all Key Company Metrics for Patterson Cos. here>>>Shares of Patterson Cos. have returned +3.2% over the past month versus the Zacks S&P 500 composite's +10.8% change. The stock currently has a Zacks Rank #3 (Hold), indicating that it could perform in line with the broader market in the near term.
Zacks Names "Single Best Pick to Double"
From thousands of stocks, 5 Zacks experts each have chosen their favorite to skyrocket +100% or more in months to come. From those 5, Director of Research Sheraz Mian hand-picks one to have the most explosive upside of all.
It’s an American AI company that’s riding low right now, but it has rounded up clients like BMW, GE, Dell Computer, and Bosch. It has prospects for not just doubling but quadrupling in the year to come. Of course, all our picks aren’t winners but this one could far surpass earlier Zacks’ Stocks Set to Double like Boston Beer Company which shot up +143.0% in little more than 9 months and NVIDIA which boomed +175.9% in one year.
Free: See Our Top Stock And 4 Runners Up
Get the latest research report on PDCO - FREE